NM_021978.4:c.36C>T
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_021978.4(ST14):c.36C>T(p.Gly12Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000035 in 1,428,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000040   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000034   (  0   hom.  ) 
Consequence
 ST14
NM_021978.4 synonymous
NM_021978.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.449  
Publications
0 publications found 
Genes affected
 ST14  (HGNC:11344):  (ST14 transmembrane serine protease matriptase) The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis. [provided by RefSeq, Jul 2008] 
ST14 Gene-Disease associations (from GenCC):
- autosomal recessive congenital ichthyosis 11Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56). 
BP6
Variant 11-130160015-C-T is Benign according to our data. Variant chr11-130160015-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2165215.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=0.449 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000395  AC: 6AN: 151760Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6
AN: 
151760
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000129  AC: 1AN: 77246 AF XY:  0.0000228   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1
AN: 
77246
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000345  AC: 44AN: 1276174Hom.:  0  Cov.: 30 AF XY:  0.0000399  AC XY: 25AN XY: 627234 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
44
AN: 
1276174
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
25
AN XY: 
627234
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
25864
American (AMR) 
 AF: 
AC: 
1
AN: 
22098
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
21534
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
27388
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
63920
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
45012
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
4288
European-Non Finnish (NFE) 
 AF: 
AC: 
40
AN: 
1014518
Other (OTH) 
 AF: 
AC: 
2
AN: 
51552
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.482 
Heterozygous variant carriers
 0 
 3 
 6 
 8 
 11 
 14 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.0000395  AC: 6AN: 151868Hom.:  0  Cov.: 32 AF XY:  0.0000404  AC XY: 3AN XY: 74228 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6
AN: 
151868
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
3
AN XY: 
74228
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41428
American (AMR) 
 AF: 
AC: 
0
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5098
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10552
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
4
AN: 
67918
Other (OTH) 
 AF: 
AC: 
1
AN: 
2100
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.492 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Apr 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.